How Do Functional Medicine Doctors Treat Autoimmune Disease?

← Back to Clinical Articles

Article: How Do Functional Medicine Doctors Treat Autoimmune Disease?  |  Category: Inflammation  |  Authored by: Brian Lamkin, DO

The Fasano Model: Three Conditions for Autoimmunity

Alessio Fasano's research has established a framework that fundamentally reframes autoimmune disease^[1]. Three conditions must converge for autoimmunity to develop: genetic predisposition (HLA genes and other susceptibility loci), an environmental trigger (infection, food antigen, toxin, or stress), and increased intestinal permeability (leaky gut). Conventional medicine cannot modify genetics. But the environmental trigger and intestinal permeability are both identifiable and treatable. Removing the trigger and restoring the barrier are the two highest-leverage interventions in autoimmune management, and neither is part of standard rheumatological care.

Why the Gut Is Central to Every Autoimmune Condition

Approximately 70 percent of the immune system resides in the gut-associated lymphoid tissue (GALT). The intestinal barrier is the primary interface between the external environment (everything ingested) and the internal immune system. When the barrier is intact, the immune system maintains tolerance: it encounters food antigens and commensal bacteria without mounting an inflammatory response^[2]. When the barrier is compromised, undigested food proteins and microbial antigens cross into systemic circulation and are presented to immune cells. In genetically susceptible individuals, this triggers molecular mimicry: the immune system attacks a foreign antigen that structurally resembles a self-tissue protein, and the immune response cross-reacts with the patient's own tissue. This mechanism has been documented in celiac disease, Hashimoto's thyroiditis, type 1 diabetes, and rheumatoid arthritis.

Step 1: Identify and Remove the Triggers

The first step in functional medicine autoimmune management is identifying what activated and what continues to stimulate the immune system. Food antigens: gluten is the most documented autoimmune trigger, producing zonulin release that directly increases intestinal permeability^[3]. Dairy casein, soy, and other proteins trigger IgG-mediated or innate immune responses in susceptible individuals. The autoimmune protocol (AIP) elimination diet removes the most common triggers for 30 to 60 days, then systematically reintroduces them to identify individual reactors. Infections: H. pylori, Epstein-Barr virus (EBV), and SIBO are all documented autoimmune triggers through molecular mimicry and chronic immune activation. Testing and treating these infections is part of the autoimmune workup. Toxins: environmental toxins (heavy metals, mold, pesticides) can activate the immune system and impair regulatory T-cell function. Stress: chronic cortisol dysregulation shifts the immune system from tolerance toward activation and directly increases intestinal permeability.

Step 2: Restore the Gut Barrier

If intestinal permeability is one of the three required conditions for autoimmunity, restoring the barrier is a logical therapeutic priority. The barrier restoration protocol follows the structured remove-replace-reinoculate-repair sequence. Remove: eliminate the identified triggers (reactive foods, infections, NSAIDs, alcohol, stress). Replace: restore digestive capacity (acid, enzymes, bile support if deficient from hypochlorhydria or biliary dysfunction). Reinoculate: rebuild the microbiome with targeted probiotics emphasizing regulatory T-cell promoting strains (Lactobacillus rhamnosus GG, Bifidobacterium infantis, Saccharomyces boulardii) and prebiotic fiber to support short-chain fatty acid production^[3]. Repair: mucosal restoration with L-glutamine (5g twice daily), zinc carnosine (75mg twice daily), vitamin D optimization, collagen peptides, and immunoglobulin support (SBI Protect). The timeline for meaningful barrier restoration is typically 3 to 6 months of sustained intervention.

Step 3: Modulate the Immune Response

Functional medicine does not suppress the immune system the way conventional immunosuppressants do. It modulates the immune response by promoting regulatory T-cell function and reducing the pro-inflammatory signaling that drives autoimmune tissue destruction. Vitamin D is one of the most potent immune modulators: vitamin D receptors are present on virtually all immune cells, and vitamin D signaling promotes regulatory T-cell differentiation while suppressing Th17 inflammatory responses^[4]. Optimization to 60 to 80 ng/mL is associated with reduced autoimmune disease activity in multiple conditions. Omega-3 fatty acids at 3 to 4g EPA/DHA daily produce specialized pro-resolving mediators (resolvins, protectins) that actively resolve inflammation rather than merely suppressing it^[5]. Low-dose naltrexone (LDN) at 1.5 to 4.5 mg at bedtime promotes endorphin-mediated regulatory T-cell function and reduces TLR4-driven inflammatory signaling. Glutathione (liposomal or IV) is the master antioxidant that supports detoxification and reduces oxidative stress-driven immune activation. Selenium at 200mcg daily has specific evidence in thyroid autoimmunity for reducing TPO antibody titers.

Step 4: Replete the Nutrients That Regulate Immunity

Autoimmune patients are frequently nutrient-depleted from malabsorption (gut inflammation impairs nutrient uptake), increased nutrient demand (chronic inflammation consumes antioxidants and cofactors), and dietary restriction (many autoimmune patients have eliminated food groups without adequate nutritional replacement). The critical nutrients for immune regulation: vitamin D (immune modulation, barrier support, regulatory T-cell promotion), zinc (immune cell differentiation, thymic function, barrier integrity), selenium (thyroid peroxidase cofactor, glutathione production, immune regulation), omega-3 fatty acids (inflammation resolution), magnesium (over 300 enzymatic reactions including immune regulation), iron (ferritin assessment, as iron deficiency impairs immune function while iron excess promotes oxidative stress), and B vitamins (methylation support, particularly B12 and folate for homocysteine metabolism and immune cell function).

The Role of the Microbiome in Immune Tolerance

Gut dysbiosis is consistently documented in autoimmune disease. Loss of microbial diversity, depletion of anti-inflammatory species (Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium species), and overgrowth of pro-inflammatory organisms shift the mucosal immune environment from tolerance to activation. Short-chain fatty acids (butyrate, propionate, acetate) produced by beneficial bacteria are direct regulators of immune tolerance: butyrate promotes regulatory T-cell differentiation and suppresses NF-kB inflammatory signaling in colonocytes. When butyrate-producing bacteria are depleted (from antibiotics, poor diet, or infection), the immune regulatory mechanism fails and autoimmune activity increases. Rebuilding the microbiome through targeted probiotics, prebiotic fiber, and dietary diversity is not a supplementary recommendation. It is a mechanistically essential intervention in autoimmune management.

Stress and HPA Axis Dysfunction in Autoimmunity

Chronic psychological stress is one of the most potent and most underappreciated autoimmune triggers. Cortisol elevation from chronic stress shifts the immune balance from Th2/regulatory toward Th1/Th17 inflammatory dominance, directly increases intestinal permeability (one of the three required conditions for autoimmunity), suppresses secretory IgA (reducing mucosal immune defense), and alters the microbiome composition toward inflammatory species. Many autoimmune patients identify a period of severe stress preceding their disease onset or their worst flares. This is not coincidence. It is the HPA axis providing the environmental trigger that, combined with genetic susceptibility and barrier compromise, activates the autoimmune cascade. Cortisol evaluation (4-point salivary or DUTCH testing) and stress management (sleep optimization, vagal tone enhancement, adaptogenic support, and in some cases structured psychological intervention) are therefore integral to autoimmune treatment.

How This Integrates with Conventional Treatment

Functional medicine autoimmune treatment is additive, not alternative. When a patient is on methotrexate for rheumatoid arthritis, a biologic for Crohn's disease, or levothyroxine for Hashimoto's hypothyroidism, those medications continue while the functional medicine protocol addresses the upstream drivers. The functional additions (barrier restoration, trigger removal, immune modulation, nutrient repletion, microbiome rebuilding, stress management) reduce the inflammatory burden that the conventional medication is suppressing. Over time, this may allow medication dose reduction under the prescribing specialist's guidance. The goal is not to stop medications abruptly. The goal is to reduce the need for medication by treating what is driving the disease, then reassess medication requirements as the underlying drivers resolve.

Monitoring Progress

Response to functional medicine autoimmune treatment is monitored through both subjective symptom tracking and objective laboratory markers. hs-CRP and sed rate track systemic inflammation (expect reduction within 3 months if triggers are being addressed). Disease-specific antibodies (TPO antibodies for Hashimoto's, rheumatoid factor and anti-CCP for RA, anti-tissue transglutaminase for celiac) are monitored at 6 to 12 month intervals. Vitamin D is monitored to confirm optimization to 60 to 80 ng/mL. Free T3 monitors thyroid function during autoimmune thyroid management. Comprehensive stool analysis tracks microbiome recovery. Fasting insulin monitors metabolic status (autoimmune inflammation drives insulin resistance). Clinical outcomes (flare frequency, symptom severity, functional capacity, quality of life) are the ultimate measure of therapeutic success.

The Lamkin Clinic Approach

Autoimmune evaluation at The Lamkin Clinic follows a structured protocol: comprehensive inflammatory markers (hs-CRP, sed rate, disease-specific antibodies), gut evaluation (comprehensive stool analysis, SIBO breath testing, food sensitivity assessment), nutrient status (vitamin D, zinc, selenium, ferritin, B12), hormonal and metabolic assessment (thyroid panel, cortisol, fasting insulin), and infection screening (H. pylori, EBV reactivation). Treatment addresses the identified triggers while implementing barrier restoration, immune modulation, nutrient repletion, and microbiome rebuilding. Conventional medications are continued and adjusted in collaboration with the prescribing specialist. The goal is to reduce disease activity at its source while managing symptoms with the minimum effective medication burden.

The Lamkin Clinic, Edmond Oklahoma | lamkinclinic.com

Frequently Asked Questions

Related Conditions

Related Clinical Articles

References and Further Reading

1. [1]Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42(1):71-78.
2. [2]Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151-175.
3. [3]Kamada N, et al. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321-335.
4. [4]Holick MF. Vitamin D and autoimmune disease. J Investig Med. 2010;59(6):881-886.
5. [5]Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.